South San Francisco

10–100 Companies
Companies
53
Growing
Deals 2019 Q1
1 investment
No acquisitions
Index Pro Account
Upgrade your account to download a CSV export of companies on any list
MedCity News

Cytokinetics remains positive on negative Phase II reldesemtiv study in ALS

Xconomy

Xconomy: Achaogen Eyes Sale in Bankruptcy Auction a Year After FDA Approval

$100,000,000 Venture capital (Series D)
PE Hub

Kinestral lands over $100 mln Series D

FinSMEs

Kinestral Technologies Secures Over $100M in Series D Funding

MedCity News

Veracyte partners with J&J on development of lung cancer test

Xconomy

MyoKardia Goes Solo as Sanofi Ends Precision Heart Drug Deal

MedCity News

Preclinical startup Jecure makes bee-line to exit with Genentech buyout

Acquisition
FinSMEs

Genentech Acquires Jecure Therapeutics

PE Hub

VC-backed Sutro Biopharma debuts IPO

$106,250,000 IPO
PE Hub

VC-backed Principia Biopharma debuts IPO

Xconomy

Entasis Therapeutics and Principia Biopharma Join the IPO Queue

$85,400,000 Venture capital (Series E)
PE Hub

Sutro Biopharma snags $85.4 mln Series E

Messaging
FinSMEs

Sutro Biopharma Raises $85.4M in Series E Funding Round

Funding Health
$75,000,000 IPO
PE Hub

VC-backed Kezar Life Sciences unveils IPO

Stock markets Health
San Francisco Chronicle

Headphones maker Monster plans $300 million cryptocurrency offering

Payments
PE Hub

Myriad Genetics to buy VC-backed Counsyl for $375 mln

Health Earnings
$375,000,000
thetechstartups

Myriad Genetics acquires genetic testing startup Counsyl for $375 million 

Earnings Science Health
Technical.ly

Senior Account Executive, SAP SuccessFactors

Cloud
GeekWire

Kineta signs multi-million dollar collaboration with Genentech to develop non-opioid pain medication

Health
Undisclosed funding
PE Hub , FinSMEs

Allogene Therapeutics grabs funding from Vida Ventures

Funding